The New England journal of medicine
-
Comment Letter
Preparing for responsible sharing of clinical trial data.
-
Editorial Comment
Sclerostin inhibition for osteoporosis--a new approach.
-
Plasmacytoid dendritic cells have been implicated in the pathogenesis of systemic sclerosis through mechanisms beyond the previously suggested production of type I interferon. ⋯ Levels of CXCL4 were elevated in patients with systemic sclerosis and correlated with the presence and progression of complications, such as lung fibrosis and pulmonary arterial hypertension. (Funded by the Dutch Arthritis Association and others.).